Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy.

Institut Gustave Roussy, Villejuif, France.

Survival: monthsCountry:France
Toxiciy Grade:4City/State/Province:Villejuif
Treatments:ChemotherapyHospital:Institut Gustave Roussy
Drugs:Journal:Link
Date:Apr 2009

Description:

Patients:
This study involved 40 men with castration-resistant prostate cancer who had previously received docetaxel-based chemotherapy. The median age was 65 years.

Treatment:
Patients were treated with the chemotherapy agents carboplatin and etoposide.

Toxicities:
The most severe reported adverse event was of grade 4. Grade 3-4 neutropenia was reported in 38% of patients and grade 3-4 anemia was reported by 25%.

Results:
The median overall survival was 19 months.

Correspondence: Dr. K. Fizazi; email: [email protected]



Back